Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5112469

Cc1ccc(-c2cccc(C)c2NC(=O)O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHIT1 Q13231 1/20 0.41
KMT2A Q03164 1/20 0.40
S1PR4 O95977 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PDK1 Q15118 1/20 0.38
PDK2 Q15119 1/20 0.38
PDK3 Q15120 1/20 0.38
PDK4 Q16654 1/20 0.38
CHRNA7 P36544 2/20 0.38
POLB P06746 3/20 0.37
KDR P35968 1/20 0.37
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
DPP4 P27487 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
MAPT P10636 3/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5111875 0.90 KDM4E (0.46) CHIT1S1PR4SMN1; SMN2LMNAHTT
Trifluoroacetic Acid SCHEMBL5100344 0.86 S1PR4 (0.46) CHIT1KMT2AS1PR4SMN1; SMN2LMNA
Trifluoroacetic Acid SCHEMBL5106740 0.84 CHRNA7 (0.42) CHIT1S1PR4SMN1; SMN2LMNAHTT
Trifluoroacetic Acid SCHEMBL5107141 0.82 HTT (0.41) CHIT1KMT2AS1PR4SMN1; SMN2LMNA
SCHEMBL3907243 0.82 KDM4E (0.51) KMT2AS1PR4SMN1; SMN2LMNAHTT
Trifluoroacetic Acid SCHEMBL5106657 0.81 S1PR4 (0.47) CHIT1S1PR4PDK1PDK2PDK3
SCHEMBL5112474 0.81 NLRP3 (0.37) KMT2AS1PR4SMN1; SMN2LMNAHTT
Trifluoroacetic Acid SCHEMBL5103332 0.81 CHRNA7 (0.47) SMN1; SMN2LMNAHTTNPSR1PDK1
Trifluoroacetic Acid SCHEMBL5111906 0.80 RAB9A (0.41) CHIT1KMT2AS1PR4SMN1; SMN2LMNA
Trifluoroacetic Acid SCHEMBL5103243 0.74 AKR1C3 (0.44) KMT2ASMN1; SMN2LMNAHTTPDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists LAINE DRAMANE I 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists CHRM3, CHRNG, CHRM2 CHIT1 3534/4885KMT2A 2510/4885S1PR4 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.